Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Myasthenia Gravis 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 19Vincristine 12Lomustine 11Temozolomide 9Procarbazine 8Cisplatin 7Carboplatin 7Etoposide 5Cyclophosphamide 5Chemotherapy, Adjuvant 5Granulocyte Colony-Stimulating Factor 4Filgrastim 4Carmustine 4etoposide phosphate 3Thiotepa 2Surgical Procedures, Operative 2Radiosurgery 2Peripheral Blood Stem Cell Transplantation 2Neoadjuvant Therapy 2Methotrexate 2Isotretinoin 2Ifosfamide 2Early Intervention, Educational 2Dihematoporphyrin Ether 2DNA Methylation 2sodium thiosulfate 1Thioguanine 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Central Nervous System Neoplasms × Leflunomide × Clear all
NCT00003293 2012-09-11

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Pfizer

Phase 3 Completed
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡